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Abstract
Introduction: Aging people’s bone regeneration potential is always impaired.
Bone marrow stromal cells (MSCs) contain progenitors of osteoblasts. Donor
age may affect MSCs’ proliferation and differentiation potential, but the genom-
ic base is still unknown. Due to recent research’s indication that a core circadi-
an component, brain and muscle ARNT-like 1 protein (BMAL1), has a role in pre-
mature aging, we investigated the normal aging mechanism in mice with their
MSCs and Bmal1 gene/protein level.
Material and methods: 1, 6 and 16 month old C57BL/6 mice were used and the
bone marrow stromal cells were gained and cultured at early passage. Bmal1
gene and protein level were detected in these cells. Marrow stromal cells were
also induced to differentiate to osteoblasts or adipocytes. Three groups of mice
MSCs were compared on proliferation by flow cytometry, on cell senescence by
SA-β-gal expression and after osteo-induction on osteogenic potential by the
expression of osterix (Osx), alkaline phosphatase (ALP) and osteocalcin (OCN).
Results: Bmal1 gene and protein level as well as S-phase fraction of the cell cycle
decreased in MSCs along with the aging process. At the same time, SA-β-gal+
levels increased, especially in the aged mice MSCs. When induced to be osteogenic,
Osx gene expression and ALP activity declined in the mid-age and aged mice MSCs,
while OCN protein secretion deteriorated in the aged mice MSCs.
Conclusions: These findings demonstrate that mouse MSCs changed with their
proliferation and osteo-differentiation abilities at different aging stages, and
that Bmal1 is related to the normal aging process in MSCs.
Key words: brain and muscle ARNT-like 1 protein, bone marrow stromal cells, aging,
differentiation, proliferation.
Introduction
In the elderly, consequences of teeth loss for the maxilla and mandible
are well known [1]. They are manifested by loss of jaw bone, especially
bone that forms the socket of the teeth on the jaw, which is termed “alve-
olar bone”, the same as other bones in the human body. The poor bone
regeneration potential will prolong or even ruin the result of orthodontic
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treatment for adult and elderly people. Losing bone
can cause an aged morphological change on the
face and impair possible implant or denture place-
ment. The aged bone loss is due to the diminished
activity of bone forming cells. Osteoblasts are
derived from progenitors residing in the bone stro-
ma. These cells are normally called bone marrow
stromal cells (MSCs) [2]. When aging, while MSCs
still have self-renewal ability and multi-differentia-
tion ability, these abilities, but the mechanism of
the aging change is still being explored.
Recently, studies have focused on BMAL1, a core
component of circadian rhythm, concerning its role
in the aging process of mammals [3, 4]. Bmal–/–
mice show early aging symptoms compared with
their wild-type littermates. These symptoms include
decreased life span, arthropathy, osteoporosis, etc.,
and the same defects do not occur in other circa-
dian gene knock-out animals. Researchers place
BMAL1 as another osteo-differentiation-related gene
changing with age, highlighting its non-circadian
functions. While formerly found in the suprachias-
matic nucleus (SCN) and controlling daily rhythm,
circadian genes are also involved in control of
homeostasis in peripheral tissues and organs. The
peripheral clocks, such as in the liver, skeletal mus-
cle, etc, while synchronized with the central circa-
dian pacemaker, can play a tissue-specific role inde-
pendently from the SCN [5]. Circadian genes are
expressed in many kinds of cells in mammalian tis-
sues, including the bone marrow stromal cells [6]. 
While early-aging symptoms of Bmal1–/– mice
aroused great interest, the normal aging changes
of Bmal1 expression in MSCs or other cells related
to their vitality are still unknown. Bmal1’s role in
aging osteogenesis change of MSCs is also lacking
any evidence. 
The purpose of the present study was to inves-
tigate the age-related effects in mouse MSCs,
namely proliferation and osteo-differentiation
potential as well as the relationship between these
changes and Bmal1 expression.
Material and methods
Animals and cell culture
Young adult (1 month old), middle-aged (6 months
old) and aged (16 months old) male C57BL/6 mice
were obtained from the Animal Centre of Sichuan
University and the operations in the study have
been approved by the University’s Bioethics Com-
mittee. Animals were housed with free access to
water and were maintained at a constant temper-
ature on a 12-h light-dark cycle. 
The cell isolation method was reported previ-
ously [7]. Briefly, both femora and tibias were
removed and soft tissues were detached. The meta-
physes from both ends of the bone were resected
and the marrow cavities were flushed with sterile
medium using a #25 gauge needle. After washing
with phosphate buffered saline (PBS) by centrifuge,
the culture was established in T25 flasks in fresh
alpha-MEM (Gibco) with 10% fetal bovine serum
(Hyclone), 100 U/ml penicillin, and 100 mg/ml strep-
tomycin (as basic medium). Cells were maintained
at 37°C in a humidified atmosphere containing 5%
CO2. After 48 h, the non-adherent cells were
removed by gentle rinsing with sterile PBS which
was pre-warmed to 37°C, and the cells maintained
in basic medium with 2~3 times per week medium
change until confluent. When confluent, the MSCs
were passaged by 0.25% trypsin and 0.01% ethyl-
enediaminetetraacetic acid (EDTA). Cells of passage
3 or 4 were used in the following experiments.
Marrow stromal cells identification, osteo- 
and adipo-differentiation procedure
Marrow stromal cells were identified as CD29(+),
Stro-1(+), CD45(–) and CD34(–) by cell immunohis-
tochemistry as other studies suggested [8]. Con-
fluent cultures of MSCs were induced to undergo
osteogenesis by basic medium supplemented with
10 nM dexamethasone, 10 mM β-glycerophosphate,
and 50 μg/ml L-ascorbate (all from Sigma, as OS
medium). After 21 days in OS medium, the osteo
cultures were rinsed in 0.9% NaCl, fixed in 70%
ethanol, and stained with 1% Alizarin Red for detec-
tion of calcium phosphate mineralization. The cul-
tures were also processed with routine von Kossa
staining.
Marrow stromal cells were induced to undergo
adipogenesis by replacing the basic medium with
adipocyte induction medium (as AD medium) com-
posed of α-MEM with 10% fetal bovine serum (FBS),
supplemented with 100 nM dexamethasone,
0.5 mM isobutylmethylxanthine (IBMX), 10 μg/ml
insulin, 0.2 mM indomethacin, 100 U/ml penicillin,
and 100 mg/ml streptomycin. After 3 days of cul-
ture with AD medium, the medium was replaced
with AD medium without IBMX and indomethacin
up to 10 days for maintenance. After that, fixed cells
were stained with 0.5% oil red O for 1 h for obser-
vation of adipogenesis. 
Flow cytometry assay
When passage 2 cells reached 80% confluence,
they were passaged 1 : 2 to a T25 flask. After 
3 days, the cells were detached with trypsin and
EDTA, twice centrifuged at 500 g for 5 min con-
taining PBS wash and then fixed with 70% alco-
hol overnight. Then the S-phase fraction of total
cells (SPF) in each sample was analysed and cal-
culated through flow cytometry (Beckman, US)
and according to the formula: SPF (%) = S/(G0/G1
+ S + G2/M) × 100%.32 Arch Med Sci 1, February / 2012
Assessment of senescence-associated 
β-galactosidase staining
Marrow stromal cells s were seeded in a 6-well
plate with 2 × 103 cell/cm2. After 2 days of culture,
the medium was discarded, cells were rinsed with
PBS once, 1 ml of fixative per well was added for 
15 min, and subsequently rinsed with PBS 3 times.
Then 1 ml per well of working solution of β-galac-
tosidase with X-Gal was placed and the plate was
maintained at 37°C overnight (senescence-associ-
ated β-galactosidase staining kit from Beyotime
China). The senescent cells were observed in an
optical microscope and counted from 5 random
fields of vision.
Real-time RT-PCR analysis
For real-time RT-PCR analysis, cells were har-
vested and maintained in RNA preservation solu-
tion (RNAsafeguard, Keygen, China) before the fol-
lowing experiment. The total RNA was extracted
using a simple P total RNA extraction kit (Bioer, Chi-
na). Total RNA was quantified, in a spectropho-
tometer, at an absorbance (A) of 260 nm. The RNA
samples had an A260 : A280 ratio of 2.0 to guar-
antee high purity. Two miligrams of total RNA from
each sample was subjected to reverse transcrip-
tion using the SYBR_ PrimeScriptTM RT-PCR Kit
(TaKaRa, China) according to the manufacturer’s
protocol. Each real time PCR was carried out in trip-
licate in a total of 20 μl reaction mixture in an ABI
PRISM 7300 Real-time PCR System (Applied Biosys-
tems, US). Primers used for real-time PCR analysis
are presented in Table I. The PCR program was con-
ducted according to the suggestion of the Takara
manual. The starting copy numbers of unknown
samples were calculated by the 7300 System SDS
Software (Applied Biosystems) from the standard
curve. The housekeeping gene β-actin was con-
currently amplified in each sample as a control and
was used for normalization. The cDNA of young
adult MSCs with or without osteo-induction nor-
malized to the level of β-actin was ascribed a fold
induction of 1. Melting curves for each PCR reac-
tion were generated to ensure the purity of the
amplification product.
Quantitative alkaline phosphatase and protein
assays
For quantitative analysis of alkaline phosphatase
activities, cells after 14 days of osteo-induction were
washed with PBS, prepared following the instruc-
tion of the alkaline phosphatase (ALP) assay kit
(Merit Choice, China). Briefly, cells were lysed with
10 mM Tris-HCl and 0.1% Triton X-100, pH 7.4 and
repeating freeze-thaw cycle for 3 times. After son-
ication, the lysates were taken for assay ALP in
a microtitre plate using p-nitrophenyl phosphate
as the substrate. The absorbance of p-nitrophenol
formed by the hydrolysis of p-nitrophenyl phos-
phate, catalysed by ALP, was measured at 405 nm
by a microplate reader (HTS 7000 Plus, PerkinElmer,
US). Total protein content was measured by the
Bradford method, read at 595 nm and calculated
according to the bovine γ globulin standards. Alka-
line phosphatase activity was expressed as unit/g
protein.
Enzyme-linked immunosorbent assay 
for osteocalcin 
To quantify and compare the concentration of
osteocalcin (OCN) in cell cultured supernatant of
the three groups of MSCs, commercially available
enzyme linked immunosorbent assay (ELISA) kits
were used according to the manufacturer’s recom-
mendations (R&D, US). Constitutive OCN secretion
was analysed after 2 weeks of osteogenic induc-
tion. Prior to collection, the supernatant of the
medium was centrifuged to remove cell debris.
Western blotting assay for BMAL1 protein level
To obtain whole-cell protein extracts, cells were
washed twice with ice-cold PBS and then lysed in
a lysis buffer (Keygen total protein extraction kit,
Keygen Biotech, China). The supernatant was col-
lected after centrifugation at 14,000g at 4°C for 
15 min and assayed quantitatively with the BCA
method. The total protein extracts were subjected
to the standard procedure of SDS-PAGE and sub-
sequent transfer to a PVDF membrane. After block-
ing, the membranes were probed with dilution of
the anti-BMAL and anti-β-actin primary antibody
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Target gene Primers  Sequence Fragment size [bp]
Bmal1 Forward primer 5’-AACCTTCCCGCAGCTAACAG-3’ 79
Reverse primer 5’-AGTCCTCTTTGGGCCACCTT-3
Osx Forward primer 5’-TATGCTCCGACCTCCTCAAC-3’ 120
Reverse primer 5’-AATAGGATTGGGAAGCAGAAA-3’
β-actin Forward primer 5’-GGGCTGTATTCCCCTCCATCG-3’ 201
Reverse primer 5’-GCAGCTCATTGTAGAAGGTGTGGTG-3’
Table I. qRT-PCR primersArch Med Sci 1, February / 2012 33
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(Abcam), followed by the addition of horseradish
peroxidase (HRP)-conjugated secondary antibody.
Immunoreactive proteins were visualized using
a chemiluminescence kit (Millipore). Band intensi-
ties were determined using the ChemiDoc XRS Gel
documentation system and Quantity One software
(Bio-Rad).
Statistical analysis
All experiments were conducted a minimum of
3 times. Measurements are expressed as mean 
± SD. Statistical comparisons were made using fac-
torial analysis of variance (ANOVA), followed by mul-
tiple comparisons using the SNK test. A value of 
p < 0.05 was considered statistically significant.
Results
Cell culture and osteoblast and adipogenic 
differentiation
Marrow stromal cells primary culture and pas-
sage 3 culture are shown in Figures 1 A-B. As can
be seen, the shape of the cells was more spindle-
like after passaging, but we cannot observe any
morphological difference among the three groups
of MSCs. Besides identification of CD (data not
shown), the MSCs isolated from three different ages
of animal can all be induced to differentiate to
osteoblasts or adipocytes at the stated time by the
differentiation medium. The common view under
phase contrast microscope after adipo-induction
and the result of Alizarin Red, von Kossa and oil red
O staining of a sample of MSCs are presented in
Figures 2 A-D.
Effects of age on cell proliferation marker 
and cellular senescence
Through flow cytometry for detection of cell cycle
phase proportion, the results showed that the 
S-phase fraction rates in 1, 6 and 16 month old mice
MSCs were 45.38 ±1.52, 37.64 ±5.72, 23.8 ±2.91 per-
cent respectively. The aged mice MSCs contained
an S-phase fraction rate which was only about half
of that in young adult MSCs. The result is present-
ed in Figure 3 A.
Marrow stromal cells isolated from young adult,
mid-age and aged mice have a growing rate of SA
β-gal+ cells. But both young adult and mid-age mice
MSCs presented an SA-β-gal+ rate lower than 5%,
which can be treated as not significant as other
researchers suggested [9]. In aged mice, the 
SA-β-gal+ cells were more than 10% of the total
count, and showed a slower proliferation rate when
passaging (data not shown), which is a sign of sus-
ceptibility to toxin in serum or capacity for senes-
cence (see Figure 3 B).
Bmal1 and Osx expression affected by age
Bmal1 gene and protein level dropped along with
age, but was much lower in aged mice MSCs. The
aged mice MSCs Bmal1 gene and protein level was
less than half of the young adult mice MSCs. And
the aged mice MSCs Bmal1/β-actin protein rate was
even less than 1 (Figures 4 A-C). 
Osx is a transcription factor that is more strong-
ly expressed in the progenitors of osteoblasts than
chondrocytes and also can be detected in MSCs,
the progenitors of osteoblasts, chondrocytes and
adipocytes. The result of RT-qPCR showed that
when MSCs were differentiated into osteoblasts by
dexamethasone, β-glycerophosphate, and L-ascor-
bate lasting for 2 weeks, their Osx gene level was
higher in the young adult and mid-age mice group
than the aged mice group (Figure 5 A).
Alkaline phosphatase activity and osteocalcin
concentration after 2 weeks of osteogenic
induction
Alkaline phosphatase activity level is an early
osteoblast marker. When comparing the three
groups of cells and detecting the ALP activity level,
the results were 15.05 ±1.81 U/g, 8 ±1.44 U/g, 
Figure 1. C57BL/6 mouse bone marrow stromal cells primary culture (A) and passage 3 culture (B) maintained in
basic culture medium were observed by phase-contrast microscope. Magnification is 100×
AB
100 μm
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3.35 ±1.43 U/g protein. The mid-age and aged
groups were much less than the young adult group.
Osteocalcin level in the supernatant of culture
medium is a late osteogenic marker for detection
of mineralization ability. Osteocalcin contents were
58.24 ±3.06, 47.49 ±3.54 and 18.65 ±3.53 ng/ml
from young adult to aged mice MSCs. The OCN
content in aged mice group was less than 1/3 of
that in the young adult group. Details are provid-
ed in Figures 5 B and C.
Discussion
The strategy of this experiment was not only to
compare young adult and aged mice MSCs’ prolif-
eration and osteo-differentiation potential, but also
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Figure 2. Characterization of C57BL/6 mouse MSCs. Passage 3 MSCs were induced to differentiate to osteoblasts by
osteo-induction medium for 3 weeks, stained with Alizarin Red (A), and von Kossa (B). Passage 3 MSCs were induced
to adipogenesis by adipo-differentiation medium for 13 days and observed in phase-contrast microscope (C) and
stained with oil red O (D). Magnification is 100× for A, B and 400× for C, D respectively
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Figure 3. MSCs were investigated on proliferation by flow cytometry and cell senescence by SA-β-gal. A – Flow cytom-
etry assay indicated that S-phase fraction cell ratio was significantly higher in 1-month group than 6-month group
and 6-month group than 16-month group. B – SA-β-gal assay is a cell senescence marker. The assay indicated that
1-month and 6-month group MSCs expressed a much lower SA-β-gal positive cell rate than 16-month group. The
values are expressed as means ± SD of at least 3 independent experiments or 5 random fields of vision
*p < 0.05 means there is a significant difference between them
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to add a mid-age group, because we believe the
aging procedure advances gradually. As expected,
the results of this study revealed that along with
aging, MSCs of C57BL/6 mice expressed more 
SA-β-gal, especially in aged mice; with the reverse
trend, the S-phase fraction ratio of all cell cycles and
the Bmal1 gene and protein level dropped. When
cells were induced to differentiate to osteoblasts,
the three osteo-differentiation markers Osx, ALP
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Figure 4. Bmal1 gene and protein level in the three
groups of C57BL/6 mouse MSCs. A – qRT-PCR results
indicate there was much lower Bmal1 mRNA expres-
sion in 6-month and 16-month groups of MSCs than
1-month group. The 16-month group’s Bmal1 mRNA
level was less than 1/3 of that in 1 month group. The
cDNA of 1-month group MSCs normalized to the lev-
el of β-actin was ascribed as a fold induction of 1. 
B, C – Western blotting results showed the same
trend of Bmal1 expression in the three groups. The
protein levels were calculated by Bmal1/β-actin pro-
tein expression ratio. The values are expressed as
means ± SD of at least 3 independent experiments
*p < 0.05 means there is a significant difference between them
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Figure 5. Osteoblast marker Osx, ALP and OCN
expression on cultured cells or supernatant of cul-
ture medium after 2 weeks of maintenance in osteo-
induction medium. A – Osx is an osteogenesis relat-
ed transcription factor. The MSCs Osx mRNA level
showed a decreasing trend, 6-month to 1-month
group and 16-month to 6-month group. The cDNA
of 1-month group MSCs normalized to the level of
β-actin was ascribed as a fold induction of 1. B – ALP
is an early marker of osteogenesis. The ALP activity
in MSCs cell lysates indicated that the level in 6-
month group and 16-month group were about half
and below 1/4 of that in 1-month group respective-
ly. C – The OCN is a late osteoblast maturation mark-
er. The OCN protein level in the supernatant of 
culture medium was calculated by ELISA. The OCN
concentration was about 18.65 ng/ml in 16-month
group MSCs compared to 47.49 ng/ml in 6-month
group and 58.24 ng/ml in 1-month group. The 
values are expressed as means ± SD of at least 
3 independent experiments
*p < 0.05 means there is a significant difference between them
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and OCN presented a consistent trend, but the pro-
portion of each age group was not exactly the same.
The Osx level decreased along with the aging
process, ALP activity was much higher in MSCs of
young adult mice, and OCN protein synthesis was
dramatically lower in MSCs of aged mice.
To find out whether there are intrinsic, senes-
cence-associated changes of MSCs in vivo, we eval-
uated the freshly isolated stromal cells at very ear-
ly passage. This strategy was intended to avoid
changes in cell behaviours that are related to pro-
longed culture [10]. Like many other types of mam-
malian cells, MSCs with repeated passaging display
“in vitro senescence”, such as decreased prolifera-
tion, replicative quiescence, enlargement and
increased SA-β-gal activity [11]. This in vitro method
was also intended to eliminate the aged-related
extrinsic somatic environment change, i.e. declines
in circulating hormones [12] when applying in vivo
study, and to focus on the intrinsic aging changes
themselves.
In the present study, there was a much lower fre-
quency of SA-β-gal positive cells and much higher
S-phase fraction of the cell cycle in young adult and
mid-age mice MSCs, compared with the aged one.
In fact, the frequency of SA-β-gal positive cells in
the former two age groups can be ignored because
the frequency was less than 5%. In older mice, the
early passage MSCs showed a frequency of 10% of
SA-β-gal positive cells, suggesting an age thresh-
old of abundantly showing this marker, suggesting
that when aging, some MSCs fail to protect them-
selves from metabolic waste or an increased level
of reactive oxygen species, etc [13]. The S-phase
fraction is a measure of the percentage of cells that
are in the phase of DNA synthesis and represents
a proliferative index of cell culture. The result of SPF
detection was consistent with our observation that
aged mice MSCs needed more time to reach con-
fluence than the other two groups under the same
culture conditions.
We detected the Bmal1 mRNA and protein level
in MSCs of the three groups. Its trend was as the
SPF ratio and as the reverse transformation of 
SA-β-gal+ ratio. The core circadian protein BMAL1,
in addition to its known functions in the circadian
oscillator, plays essential non-redundant roles in
the control of tissue homeostasis and aging. One
of the most striking phenomena was premature
aging of Bmal1–/– animals [3]. While there are no
morphological differences between Bmal1–/– ani-
mals and their wild-type littermates at birth and
early age, 18-week-old Bmal1–/– mice showed signs
of growth retardation and 36-week-old knockout
mice morphologically resembled aged mice. The
study suggested that the control of aging is a nov-
el function of Bmal1, relatively independent from
its role in the circadian oscillator. Along with our
study results, the Bmal1 gene and protein level were
much lower in older mice’s MSCs, and the fre-
quency of SA-β-gal positive cells was much higher
as well. We can speculate that Bmal1 reduction or
malfunction can also be a candidate reason of
MSCs in vivo ageing or cell senescence [14]. Because
BMAL1 was reported to participate in controlling
glucose and fat metabolism and homeostasis [15,
16], and MSCs are the progenitors of adipocytes,
chondrocytes and osteoblasts, the hypothesis may
be convincing. Recently, studies showed that cyclin-
dependent kinase inhibitor p21, which negatively
regulates the G1/S phase transition, is antagonized
by Bmal1 through the orphan nuclear receptor
ROR/REV-ERB pathway with or without a relation-
ship with p21’s regulator, p53 [17, 18]. These inves-
tigations established a novel molecular link
between clock and cell cycle genes. Because ROR
and REV-ERB are BMAL1’s activator and repressor
respectively, the three transcriptional factors can
form an interlock loop that plays a stabilizing role
in circadian rhythm [19, 20]. This may be the rea-
son why the aged mice MSCs showed a much more
decreased Bmal1 level and SPF rate as well.
In aging, bone formation activity is significantly
reduced. It has been postulated that a deficiency
in osteoprogenitor cells is the main reason for the
decline in bone induction activity [21]. This is
because osteoprogenitor cells play a major role not
only in bone formation but also in bone resorption
[22, 23]. In contrast, a few researchers found no
effects of age-related decline in osteoblast poten-
tial when applying colony assays for the numbers
of colonies that stain for alkaline phosphatase [24].
Osteoblast differentiation is regulated by a com-
plex network of transcription factors and different
signalling pathways. Osteoblastic differentiation in
vitro is also characterized by three distinct stages
of cellular activity: proliferation, extracellular matrix
(ECM) maturation and mineralization [25, 26]. So
we recruited three indices of osteoblast differenti-
ation: transcriptional factor Osx, early osteogenic
marker ALP and late osteogenic marker OCN,
hypothesizing that their aging evolvement would
be different. As we expected, the Osx level in MSCs
decreased gradually with aging of the mice, reveal-
ing a different response to osteogenic activation.
The early osteoblast marker ALP activity was also
higher in young adult mice MSCs, but much lower
in mid-age and aged mice MSCs. However, while
ALP level was much lower in mid-age MSCs than
young adult MSCs, the late osteoblast marker, OCN
level, was not statistically different between the
two groups, and it needs to be stressed that the
aged mice showed the dramatically lowest level of
OCN. Our research results showed a gradual change
of osteogenic ability along with aging with osteo-
differentiation indices.
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While some investigators believe that the reduc-
tion of bone mass in older persons is not caused
by a shift in differentiation of these precursors
towards adipocytes, others did not agree with that
viewpoint [27, 28]. If so, there must be some aging
intrinsic changes or signalling pathway with respect
to their differentiation potential. Aging alters the
circadian biology in several aspects including the
circadian components [29] and there have been
clues linking circadian rhythms to bone metabo-
lism: clinical studies have detected 24-h oscillations
in human serum levels of osteocalcin and alkaline
phosphatase [30, 31]. A recent study showed that
a circadian gene could mediate leptin-dependent
bone formation [32]. CLOCK and BMAL1 proteins
heterodimerize to form a transcriptional factor but
the CLOCK mutant did not show the same symp-
tom of pre-aging as Bmal1–/– mice; this indicated
that Bmal1 decided the complete functionality of
the complex or else BMAL1 deficiency would affect
activities of different systems [33, 34]. The circadi-
an clock affects physiological processes through the
regulation of the clock-controlled gene or output
gene. The clock-controlled genes are tissue-specif-
ic and some osteogenic related genes can be con-
trolled by the circadian clock or Bmal1 in bone mar-
row and MSCs [5, 35]. In another way, the
mechanism of Bmal1 controlling aged osteogenic
potential change is still unclear. Recent information
showed that ROR, a positive regulator and target
of Bmal1, must be an imperative modulator of bone
sialoprotein and dentin matrix protein 1 involved in
the osteoblast differentiation and bone formation.
And Bmal1’s other antagonized target, p53, is a neg-
ative regulator of osteoblast differentiation [36-38].
These can be clues for future study.
We have shown the normal aging effects on
murine MSCs proliferation and differentiation, and
with the aforementioned information in mind, we
concluded that besides its effects on mice MSCs
proliferation, Bmal1 could play a role in the late
stage of osteoblast maturation and mineralization.
The results must be further tested using murine
models harbouring conditional alleles of Bmal1 that
allow tissue-specific deletion or overexpression as
well as in osteoblasts or MSCs.
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